LBF20307PG39: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
{{Metabolite | {{Metabolite |
Revision as of 00:30, 27 July 2009
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR8046 |
LipidMaps | LMFA03010092 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20307PG39 |
15-epi-prostaglandin A2 | |
---|---|
Structural Information | |
(5Z, 13E) - (8R,12S,15R) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid | |
| |
Formula | C20H30O4 |
Exact Mass | 334.21440944799997 |
Average Mass | 334.4498 |
SMILES | C(CC[C@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C=CC(=O)1)CC |
Physicochemical Information | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | nfilmmax1350 and 970cm-1 Weinheimer_AJ et al. |
NMR Spectra | 1H-NMRdppm5.41, 5.58. Weinheimer_AJ et al. |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|